Patent Number: 6,251,852

Title: Combination therapy for reducing the risks associated with cardiovascular disease

Abstract: The instant invention involves a combination therapy and pharmaceutical compositions comprised of a therapeutically effective amount of a cholesterol reducing agent such as an HMG-CoA reductase inhibitor in combination with a platelet aggregation inhibitor which is useful for inhibiting platelet aggregation, for inhibiting the formation of thrombotic occlusions, and for treating, preventing and reducing the risk of occurrence of cardiovascular and cerebrovascular events and related vaso-occlusive disorders.

Inventors: Gould; Robert J. (Green Lane, PA), Nichtberger; Steven A. (New Rochelle, NY), Rhymer; Patricia A. (Martinsville, NJ), Olofsson; Lars (.ANG.kersberga, SE)

Assignee: Merck & Co., Inc.

International Classification: A61K 45/00 (20060101); A61K 45/06 (20060101); A61K 038/00 (); C07K 005/00 (); C07K 007/00 ()

Expiration Date: 06/26/2018